Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Icovamenib by Biomea Fusion for Type 2 Diabetes: Likelihood of Approval
Icovamenib is under clinical development by Biomea Fusion and currently in Phase II for Type 2 Diabetes. According to GlobalData,...
Icovamenib by Biomea Fusion for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Icovamenib is under clinical development by Biomea Fusion and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes). According...
Icovamenib by Biomea Fusion for Solid Tumor: Likelihood of Approval
Icovamenib is under clinical development by Biomea Fusion and currently in Phase I for Solid Tumor. According to GlobalData, Phase...